DK2054050T3 - Treatment of cartilage disease with FGF-18 - Google Patents

Treatment of cartilage disease with FGF-18

Info

Publication number
DK2054050T3
DK2054050T3 DK07802876.8T DK07802876T DK2054050T3 DK 2054050 T3 DK2054050 T3 DK 2054050T3 DK 07802876 T DK07802876 T DK 07802876T DK 2054050 T3 DK2054050 T3 DK 2054050T3
Authority
DK
Denmark
Prior art keywords
fgf
treatment
cartilage disease
cartilage
disease
Prior art date
Application number
DK07802876.8T
Other languages
Danish (da)
Inventor
Christoph H Ladel
Alberto Gimona
Baur Elmar Vom
Original Assignee
Ares Trading Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ares Trading Sa filed Critical Ares Trading Sa
Priority claimed from PCT/EP2007/058830 external-priority patent/WO2008023063A2/en
Application granted granted Critical
Publication of DK2054050T3 publication Critical patent/DK2054050T3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
DK07802876.8T 2006-08-25 2007-08-24 Treatment of cartilage disease with FGF-18 DK2054050T3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06119557 2006-08-25
US84060006P 2006-08-28 2006-08-28
PCT/EP2007/058830 WO2008023063A2 (en) 2006-08-25 2007-08-24 Treatment of cartilage disorders with fgf-18

Publications (1)

Publication Number Publication Date
DK2054050T3 true DK2054050T3 (en) 2012-09-03

Family

ID=37684849

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07802876.8T DK2054050T3 (en) 2006-08-25 2007-08-24 Treatment of cartilage disease with FGF-18

Country Status (11)

Country Link
CN (1) CN101505787B (en)
BR (1) BRPI0715728A8 (en)
DK (1) DK2054050T3 (en)
ES (1) ES2392883T3 (en)
MY (1) MY148277A (en)
NZ (1) NZ574216A (en)
PT (1) PT2054050E (en)
RS (1) RS52710B (en)
SI (1) SI2054050T1 (en)
UA (1) UA99818C2 (en)
ZA (1) ZA200900426B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10221456B2 (en) * 2012-08-06 2019-03-05 Merck Patent Gmbh Genetic markers for predicting responsiveness to FPG-18 compound
EP3107592B1 (en) * 2014-02-20 2018-08-22 Merck Patent GmbH Implant comprising fgf-18
US20170056554A1 (en) * 2014-02-20 2017-03-02 Merck Patent Gmbh Fgf-18 in graft transplantation and tissue engineering procedures
AR099510A1 (en) * 2014-02-20 2016-07-27 Merck Patent Gmbh FGF-18 COMPOSITE DOSAGE REGIME
EP3250223A1 (en) * 2015-01-08 2017-12-06 University of Iowa Research Foundation Methods for the regeneration of articular cartilage in vivo
JP6951318B2 (en) * 2015-07-15 2021-10-20 プロージット ソウル バイオテクノロジー （ベイジン） カンパニー リミテッド Fusion polypeptide and usage
WO2017025611A1 (en) * 2015-08-13 2017-02-16 Merck Patent Gmbh Combination composition comprising fgf-18 compound
US11904006B2 (en) 2019-12-11 2024-02-20 University Of Iowa Research Foundation Poly(diaminosulfide) particle-based vaccine
CN117721115A (en) * 2022-09-06 2024-03-19 深圳瑞吉生物科技有限公司 mRNA for treating osteoarthritis and preparation method and application thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4754823B2 (en) * 2002-10-07 2011-08-24 ザイモジェネティクス， インコーポレイテッド Administration method of FGF18
EP1896053B1 (en) * 2004-07-06 2018-10-31 ZymoGenetics, Inc. Pharmaceutical composition comprising fgf18 and il-1 antagonist and method of use
CA2592261C (en) * 2004-12-10 2015-11-24 Zymogenetics Inc. Fgf18 production in prokaryotic hosts

Also Published As

Publication number Publication date
NZ574216A (en) 2011-11-25
SI2054050T1 (en) 2012-12-31
PT2054050E (en) 2012-09-17
ZA200900426B (en) 2010-04-28
UA99818C2 (en) 2012-10-10
BRPI0715728A8 (en) 2018-04-03
RS52710B (en) 2013-08-30
ES2392883T3 (en) 2012-12-14
MY148277A (en) 2013-03-29
BRPI0715728A2 (en) 2013-09-17
CN101505787B (en) 2013-09-04
CN101505787A (en) 2009-08-12

Similar Documents

Publication Publication Date Title
DK1986633T3 (en) TREATMENT OF DUCHENNES MUSCLE DYSTROPHY
DK2056807T3 (en) Treatment of inflammatory diseases
DK2054050T3 (en) Treatment of cartilage disease with FGF-18
LTPA2016033I1 (en) Remedies for treatment of Fabri disease
PL2054050T3 (en) Treatment of cartilage disorders with fgf-18
DK2700786T3 (en) Modification of transfer passage
DK2222272T3 (en) Treatment of respiratory disease
DK2084174T3 (en) Preparation of ribofuranosylpyrimidine nucleotides
DK2982696T3 (en) TREATMENT OF ACUTE Lymphoblastogenic Infections
DK1890684T3 (en) Treatment of sleep / wakefulness disorders
ATE528296T1 (en) POLYMORPHOUS FORM OF 4-Ä3-(4-CYCLOPROPANCARBONYLPIPERAZINE-1-CARBONYL)-4-FLUORBENZYLÜ-2H-PHTHALAZIN-1-ONE
DK1976516T3 (en) TREATMENT OF VIRAL HEPATITIS
DK1874781T3 (en) Dihydrothienopyrimidines for the treatment of inflammatory diseases
BRPI0811265A2 (en) TREATMENT OF SYNUCLEINOPATHIES
DK2219469T3 (en) MODIFICATION OF ENZYMATICALLY DISPOSED PROTEINS
BRPI0815551A2 (en) TREATMENT THROUGH HUCBC OF BETA-AMYLOID DISEASE
DK2034830T3 (en) ANTI-VLA-1 ANTIBODY FOR TREATMENT OF CASES
DK1962869T3 (en) Treatment of respiratory diseases
DK1981506T6 (en) LONG TERM TREATMENT OF HIV INFECTION WITH TCM278
DK2087176T3 (en) Cleaning of artificial turf
DK2056858T3 (en) TREATMENT OF LUNG DISEASE CONDITIONS
DK2117565T3 (en) APPLICATION OF CHITOSANES FOR THE TREATMENT OF NON-FLAMMATORY DISEASES
DK2175849T3 (en) Treatment of melanomas
DK2190451T3 (en) TREATMENT OF ATHEROSCLEROSIS
DK2049123T3 (en) DELAYED RELEASE GLUCOCORTICOID TREATMENT OF RHEUMATOID DISEASE